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The subject of substance abuse and psychosis has been studied extensively and many authors have discussed the relationship between drug consumption by psychiatric patients and illness outcome. [1] [2] [3] Previous attempts to determine'cause and effect' retrospectively have largely been unreliable, given the general lack of knowledge of early prodromal symptoms in most psychiatric disorders. Findings on the temporal relationship between substance abuse in general and illness onset are inconsistent, but some data suggest that cannabis abuse may precipitate schizophrenia. 4 Most studies suggest a high prevalence of substance abuse in patients with psychotic disorders. 3 In fact, substance abuse by patients with schizophrenia seems to be the rule rather than the exception! Prevalence rates among young patients with schizophrenia range from 25% to 60%. 2, 5 In a large Epidemiological Catchment Area study, 2 young schizophrenic patients abused alcohol or drugs three times as often as the same age groups in the general population.
This association raises further questions on the relationship between the two disorders, viz. whether substance abuse precipitates or is a consequence of schizophrenia, whether substance abuse affects the outcome of psychotic disorders and vice versa, whether there is a subgroup of patients with schizophrenia who are prone to abuse substances, whether there is a shared risk for the two disorders, and if there is any difference in treatment requirements and outcome over time between patients who abuse substances and those who do not.
Despite the aforementioned research into the relationship between the disorders, few studies have examined co-morbidity with first-episode psychosis. A recent study in the UK by Cantwell et al. 6 confirmed high rates (37%) of substance abuse at onset of first psychosis. It also showed young males to be the group most at risk. In another study of first-episode psychosis and substance abuse by Strakowski et al. 7 it was found that 56% of first-episode psychosis patients met the criteria for substance abuse, making it Relationship between substance abuse and first-episode psychosis 
O b j e c t i v e s .
To determine the effect of substance abuse on psychosis in terms of onset, duration, severity of symptoms, use of medication and outcome.
M e t h o d .
T h i rt y -t h ree subjects with first-episode psychosis, as well as primary caregivers, were interviewed re g a rding substance abuse and its relation to illness. Thirty-six control subjects were also interv i e w e d .
R e s u l t s .
Twenty-seven per cent of subjects abused substances in the 3 months before onset of illness, and 77.8% of the abusers w e re male. Subjects in the first-episode psychosis group were m o re likely to choose cannabis as their substance of abuse than c o n t rols. They also started abusing substances at a younger age than controls. Subjects with first-episode psychosis who abused substances presented at an earlier age than non-abusers.
Substances affected symptoms at baseline pre s e n t a t i o n . In this study we specifically examined patients presenting with a first episode of psychosis in order to avoid a confounding factor present in previous studies, i.e. the uncertain effect of long-term illness and treatment on the diagnosis of co-morbidity. 7 By studying patients with first-episode psychosis many confounding factors are avoided and the illness can largely be observed in its 'natural' state.
Subject s and met hods
Sixty-nine subjects were included in this study, 33 in the first- 
Result s Char act er i st i cs of t he sampl e
Thirty-three subjects were included in the first-episode psychosis group. Eighteen (55%) of these subjects were male and 15 (45%) female. The mean age was 29.25 years (± 9.07 years).
Twenty-six (79%) of subjects were of mixed racial origin, and 7
(21%) were Caucasian.
Thirty-six subjects were included in the control group. They were matched for age, gender and race. Twenty (56%) of these subjects were male and 16 (44%) female. The mean age was 29.6
years. Twenty-eight individuals (78%) were of mixed racial origin, 5 (14%) Caucasian and 3 (8%) black. Individual interviews conducted with all these subjects elicited birth history and demographic data, while a separate questionnaire and the SCID-P drug and alcohol section established alcohol and drug habits.
There were no statistically significant differences between the two groups in terms of age, gender or race.
Subst ance and al cohol use and abuse
Nine of the 33 first-episode psychosis subjects (27%) had used substances more than once a week in the 3 months before the onset of their first episode of psychosis. Seven of these 9 abusers (77.8%) were male. These findings are similar to those of previous studies which show substance abuse to be common in psychiatric populations (up to 30%). 3 Only 2 subjects were diagnosed as ongoing drug abusers at follow-up. In the control group, 4 of the 36 subjects (11%) had used substances more than once a week in the 3 months before the interview. Although there is a seemingly large numerical difference between the two groups, it did not reach statistical significance (p = 0.124,
Fisher's exact test, two-tailed). The reason for this finding is most
probably the small sample size, but it might also reflect high substance abuse rates in the general population of the Western
Cape.
There was no significant difference between the two groups in terms of lifetime risk of substance use. Twenty-eight of 33 subjects in the study group admitted to having ever used a substance or alcohol, compared with 26 of 36 subjects in the control group
A most intriguing finding was a significant difference in the choice of substance between the study and control groups ( Figs   1 and 2) . Subjects from the first-episode psychosis group were more likely to choose cannabis than controls (p = 0.03).
There were no differences between subjects who abused sub- However, we found a significant difference between subjects in the first-episode group and controls in terms of age that they first used substances, with the first-episode group starting at a significantly younger age (10 -15 years) than controls (15 -20 years) (χ 2 = 10.02, df = 4, p = 0.04).
Also, in the first-episode psychosis group, those subjects who abused substances had onset of psychosis at a significantly younger age than those who did not (p = 0.01).
Furthermore, we found significant differences between substance abusers and non-abusers in terms of symptom severity at baseline Further analysis of specific items on the PANSS showed that two items of the PANSS positive scale differed significantly between the two groups. These were the ratings P2 (conceptual disorganisation) and P3 (hallucinatory behaviour) (p = 0.002 and p = 0.019).
Discussion
Our results confirm that substance abuse is a significant problem among first-episode psychosis patients in the Western Cape.
When interpreting the results it must be borne in mind that 'substance' in this study refers mainly to cannabis, as this was the drug most often abused by study subjects. Results cannot, therefore, be extrapolated to other substances of abuse, such as hallucinogens and stimulants.
Our results suggest that, in our study population, substance abuse did not affect the duration of the untreated psychosis.
However, in those patients who abused substances, psychotic illness presented at a younger age than in those patients who did not. This finding can be interpreted in two ways. Firstly, it may indicate that patients with an inherently poorer prognosis (as seen with earlier onset) are at increased risk for abusing substances, either as a form of self-medication or because of a shared risk between the two disorders. 4 Alternatively, our finding may support the theory that substance abuse precipitates psychotic illness in the predisposed individual, thereby lending support to the so-called vulnerability hypothesis. 10 The finding that patients started abusing substances at an earlier age than subjects from the control group is also of great interest and importance. It seems that patients who are predisposed to a psychotic illness are more prone to abusing substances than normal subjects of the same age. It is therefore possible that the two disorders (psychosis and substance abuse) share common risk factors.
Although 77.8% of patients who abused substances in the 3 months before their first psychotic episode were male, there were no significant gender differences between substance users and non-users on follow-up. This was probably due to the small number in the follow-up group.
The use of substances had a significant effect on PANSS ratings at baseline evaluation. Substance abusers scored higher on PANSS subscales for positive, negative, and general psychopathology, but also on PANSS total scores. Specific factors that correlated strongly were P2 (conceptual disorganisation) and P3 (hallucinatory behaviour). It seems, therefore, that substanceabusing subjects presented differently from the non-abusers, but that these differences were not observed at follow-up, probably as a result of the fact that these patients did not continue with the substance abuse after admission to hospital. This correlates with the fact that the number of substance abusers also decreased at follow-up. It suggests that substances in general and cannabis in particular cause increased severity of perceptual disturbances and thought process disorders in the acute phase of psychosis.
This clinical effect may be mediated via the effect of delta-9-tetra hydrocannabinol on the dopamine receptors in the medial forebrain bundles, 8 but other, as yet unknown mechanisms may also be involved.
There were no differences in outcome over a 6-month period between substance-abusing subjects and non-abusers. This may again be due to the fact that substance abuse was not an ongoing problem with most patients, but mainly seen before and at onset of the psychosis. This finding supports the suggestion that psychotic patients use substances (specifically cannabis) to selfmedicate their symptoms. 11 It may also imply that initiation of adequate treatment (i.e. optimal symptom relief and minimal side-effects) removed the need for ongoing substance abuse.
It should be remembered, however, that substance and/or alcohol dependence were exclusion criteria in this study. This fact may have influenced our findings to some extent, and should be considered in the interpretation of the results. We also found no difference in the dosages of medication needed for remission between those who used substances and those who did not.
Substance-abusing psychotic patients therefore did not constitute a more treatment-refractory group, as we initially thought.
In our study population, substance use is common in both the general and the psychiatric population. Substance use, even in fairly moderate quantities, may have an effect on the onset and presentation of psychotic illness, but does not seem to have a major effect on treatment response and outcome in a firstepisode population. Once again, this statement should be read with the understanding that patients who were clearly substancedependent were excluded from the study altogether .
There are certain obvious limitations to this study. action and other confidentiality issues. We did attempt to overcome this problem by using collateral information from primary caregivers, but even this method is fallible. Primary caregivers often admitted that they were not sure about the patients' substance habits.
Although the age criteria included children from the age of 14 years, only adults were seen in this study, mainly due to the fact that Stikland Hospital only accepts adults.
As already mentioned, the sample size was fairly small, which might have compromised some of the results. The study population should be expanded to enhance the statistical power of the study.
Conclusion
The following conclusions may be drawn from this study: (i) there is a high co-morbidity between first-episode psychosis and substance abuse in South Africa (27%), although this needs to be seen against the background of a generally high level of substance abuse in this country; (ii) subjects who abuse substances present with the first episode of psychosis at a younger age than those who do not; (iii) first-episode psychosis subjects start abusing substances at a younger age than control subjects; (iv) substance abuse affects presenting symptoms of subjects with a first episode of psychosis; (v) first-episode psychosis subjects are more likely to choose cannabis as their substance of abuse; and (vi) males are more likely to abuse substances than females.
